Nhlbi trans-omics for precision medicine (topmed) for the centralized omics resource (core)

Active Indefinite Delivery Contract Awarded Last action

Contract number
75N92023D00013
Awardee
Awarding agency
Task orders
4 $38,147,685 obligated

Award facts

Opportunity
Combined order value
  • $38,147,685 Current, with exercised options
  • $64,639,921 Potential, with all options
Last date to order 31% complete
IDV ceiling 8% used
$500,000,000.00
Award type
Single award
Who can order
Only the awarding agency
Set-aside
No set-aside
Competition
Full and Open Competition · 13 offers Negotiated Proposal / Quote
Pricing
Firm Fixed Price
Legislative mandates

Award details come from SAM.gov/FPDS.

About this IDV

The National Heart, Lung and Blood Institute awarded a single-award indefinite delivery contract to The Broad Institute, Inc. on September 12, 2023, with a ceiling value of $500 million for the Trans-Omics for Precision Medicine (TOPMed) Centralized Omics Resource (CORE). The Broad Institute is a non-profit biomedical and genomic research organization.

Place of performance is Cambridge, Massachusetts. The IDIQ supports genomic sequencing, analysis, and precision medicine data infrastructure for the TOPMed initiative, which develops omics-based research capabilities to advance personalized medicine across disease domains. The contract runs through September 11, 2033.

The originating solicitation, posted as a capability questionnaire in May 2022, sought demonstration of complex data analysis, integration, and management of large-scale genomic and health datasets. The Broad Institute demonstrated capability in computational biology, large-scale sequencing platforms, and data integration infrastructure supporting precision medicine research.

Four delivery orders have been issued under this IDIQ. The most recent, awarded September 28, 2026, totals $12.7 million for continued TOPMed CORE support through September 27, 2030 on a firm fixed price basis. A prior order issued September 26, 2025, was valued at $23.4 million through September 25, 2027. An order from September 23, 2024, covering Task Areas 2, 3, and 4, totaled $24.9 million through September 22, 2027. An initial order issued September 28, 2023, for Task Areas 2, 3, and 4, was valued at $3.6 million through September 27, 2027. All orders specify Cambridge, Massachusetts as the place of performance and carry firm fixed price terms with no set-aside designation.

Task orders

Transactions

Action Obligated Date
Other Administrative Action P00001 · EO14398, RFO, INV, non-commercial BOT nhlbi trans-omics for precision medicine (topmed) for the centralized omics resource (core) $0
Original award $0

Quick answers

Who was awarded contract 75N92023D00013?

75N92023D00013 was awarded to The Broad Institute, Inc. by National Heart Lung and Blood Institute (National Institutes of Health) on September 12, 2023.

How much is contract 75N92023D00013 worth?

Orders under 75N92023D00013 have obligated $38,147,685. Their combined potential value, with all options, is $64,639,921. 75N92023D00013's own ceiling is $500,000,000.

How many orders have been placed under contract 75N92023D00013?

4 orders have been placed under 75N92023D00013, the latest on September 28, 2026.

Who can order from contract 75N92023D00013?

75N92023D00013 is a single award indefinite delivery contract. Only the awarding agency can place orders on it.

Was contract 75N92023D00013 competed?

The extent of competition for 75N92023D00013 was full and open competition. The government received 13 offers.

On GovTribe

See this IDV's full record

  • Every order and transaction
  • The awardee's other awards and teaming partners
  • Similar IDVs and recompete opportunities
  • Ask GovTribe AI about this IDV